NORTHSTAR ASSET MANAGEMENT Co trimmed its holdings in shares of Danaher Corporation (NYSE:DHR – Free Report) by 2.4% in the second quarter, HoldingsChannel reports. The institutional investor owned 32,385 shares of the conglomerate’s stock after selling 800 shares during the quarter. Danaher accounts for 1.5% of NORTHSTAR ASSET MANAGEMENT Co’s portfolio, making the stock its 15th biggest position. NORTHSTAR ASSET MANAGEMENT Co’s holdings in Danaher were worth $6,397,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. GAMMA Investing LLC lifted its stake in Danaher by 22.2% in the first quarter. GAMMA Investing LLC now owns 9,126 shares of the conglomerate’s stock valued at $1,871,000 after buying an additional 1,660 shares during the period. Pacific Capital Partners Ltd bought a new position in Danaher during the 1st quarter worth approximately $7,175,000. GHP Investment Advisors Inc. grew its holdings in Danaher by 396.0% during the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock valued at $25,000 after purchasing an additional 99 shares during the period. International Assets Investment Management LLC increased its stake in Danaher by 39.5% in the first quarter. International Assets Investment Management LLC now owns 2,191 shares of the conglomerate’s stock valued at $449,000 after purchasing an additional 620 shares in the last quarter. Finally, Golden State Wealth Management LLC raised its holdings in Danaher by 356.0% in the first quarter. Golden State Wealth Management LLC now owns 611 shares of the conglomerate’s stock worth $125,000 after purchasing an additional 477 shares during the period. 79.05% of the stock is owned by institutional investors.
Insider Activity
In related news, Director Teri List sold 2,778 shares of the company’s stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 11.10% of the company’s stock.
Wall Street Analyst Weigh In
View Our Latest Research Report on Danaher
Danaher Stock Up 0.1%
Shares of Danaher stock opened at $223.03 on Friday. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $258.23. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.22 and a current ratio of 1.52. The business’s 50 day simple moving average is $202.73 and its 200 day simple moving average is $198.36. The firm has a market cap of $157.54 billion, a PE ratio of 45.99, a P/E/G ratio of 3.41 and a beta of 0.77.
Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings data on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. The company had revenue of $6.05 billion for the quarter, compared to the consensus estimate of $6 billion. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The firm’s revenue was up 4.4% compared to the same quarter last year. During the same period last year, the company earned $1.71 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, analysts predict that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.
Danaher Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be issued a $0.32 dividend. The ex-dividend date is Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s dividend payout ratio (DPR) is presently 26.39%.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles
- Five stocks we like better than Danaher
- Asset Allocation Strategies in Volatile Markets
- MarketBeat Week in Review – 10/20 – 10/24
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Rayonier-PotlatchDeltic Merger Signals Industry Upside
- Stock Market Upgrades: What Are They?
- Hims & Hers Short Interest Nears All-Time High, Buy The Dip?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
